Stereotaxis (STXS) Swings to Q3 Loss
Tweet
Share
E-mailGet Alerts STXS Hot Sheet
Join SI Premium – FREE
Stereotaxis (NASDAQ: STXS) reported Q3 EPS of ($0.05), versus $0.00 reported last year. Revenue for the quarter came in at $9.3 million, versus $8.9 million reported last year.
For earnings history and earnings-related data on Stereotaxis (STXS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
- Outlook Therapeutics posts Q3 loss, eyes U.S. LYTENAVA launch by end of 2026
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
